Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert McShane

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Affective Disorders|May 17, 2026
Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American society of ketamine physicians, psychotherapists, and practitioners (ASKP3)David S Mathai, Madeleine Cluck, Amna M Aslam, et al.
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAnna H Noel-Storr, Leon Flicker, Craig W Ritchie, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
Neurology|June 20, 2014
Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem InitiativeAnna H Noel-Storr, Jenny M McCleery, Edo Richard, et al.
The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trialKirsty Forsyth, Catherine Henderson, Lucy Davis, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Affective Disorders|May 17, 2026
Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American society of ketamine physicians, psychotherapists, and practitioners (ASKP3)David S Mathai, Madeleine Cluck, Amna M Aslam, et al.
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAnna H Noel-Storr, Leon Flicker, Craig W Ritchie, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
Neurology|June 20, 2014
Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem InitiativeAnna H Noel-Storr, Jenny M McCleery, Edo Richard, et al.
The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trialKirsty Forsyth, Catherine Henderson, Lucy Davis, et al.
Pageof 7